Glioma immunotherapy group
11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
- Contribution to journal › Article
- 2021
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
- Contribution to journal › Article
-
Mark
Circular rnas in hedgehog signaling activation and hedgehog‐mediated medulloblastoma tumors
- Contribution to journal › Article
- 2020
-
Mark
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(33). p.20127-20138
- Contribution to journal › Article
-
Mark
Immunological aspects of intratumoral chemotherapy and immunotherapy in malignant brain tumors
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas
- Contribution to journal › Article
- 2019
-
Mark
The molecular landscape of ETMR at diagnosis and relapse
- Contribution to journal › Article
-
Mark
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration
- Contribution to journal › Article
-
Mark
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model
- Contribution to journal › Article
- 2002
-
Mark
Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells
- Contribution to journal › Article
